Thy-1 signaling in the context of costimulation provided by dendritic cells provides signal 1 for T cell proliferation and cytotoxic effector molecule expression, but fails to trigger delivery of the lethal hit

Journal of Immunology

Volumn 171, Issue 1, 2003, Pages 69-77

  Haeryfar, S M Mansour ^a   Al Alwan, Monther M ^a   Mader, Jamie S ^a   Rowden, Geoffry ^a   West, Kenneth A ^a   Hoskin, David W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOTOXIC EFFECTOR MOLECULE; FAS LIGAND; FC RECEPTOR; GRANZYME B; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PERFORIN; PROTEIN; PROTEIN HIT; T LYMPHOCYTE RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL KILLING; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TARGET CELL;

EID: 0037531428     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.1.69     Document Type: Article

References (52)

1. Liu, Y., and P. S. Linsley. 1992. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:265.
2. Van Wauwe, J. P., J. R. De Mey, and J. G. Goossens. 1980. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J. Immunol. 124:2708.
3. Leo, O., M. Foo, D. H, Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
4. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
5. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
6. L. Immunol. 3:87.
7. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
8. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
9. Killeen, N. 1997. T-cell regulation: Thy-1 hiding in full view. Curr. Biol. 7:R774.
10. Gunter, K. C., T. R. Malek, and E. M. Shevach. 1984. T cell-activating properties of an anti-Thy-1 monoclonal antibody: possible analogy to OKT3/Leu-4. J. Exp. Med. 159:716.
11. Kroczek, R. A., K. C. Gunter, B. Seligmann, and E. M. Shevach. 1986. Induction of T cell activation by monoclonal anti-Thy-1 antibodies. J. Immunol. 136:4379.
12. -/- mice show augmented TCR signaling and impaired differentiation. Curr. Biol. 7:705.
13. Johnson, R., D. W, Lancki, and F. W. Fitch. 1993. Accessory molecules involved in antigen-mediated cytolysis and lymphokine production by cytotoxic T lymphocyte subsets. 1. Identification of functions for the T cell surface molecules Ly-6C and Thy-1. J. Immunol. 151:2986.
14. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
15. Al-Alwan, M. M., G. Rowden, T. D. Lee, and K. A. West. 2001. The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J. Immunol. 166:1452.
16. + T cells by infected dendritic cells in vivo. Nat. Immun. 3:265.
17. lo thymocytes in vivo. Science 250:1720.
18. Lee, R. K., J. Spielman, and E. R. Podack. 1996. Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int. Immunol. 8:991.
19. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
20. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77.
21. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645.
22. Kaiser, M., J. Brooks-Kaiser, L. Fitzpatrick, R. C. Bleackley, and D. W. Hoskin. 1993. Cytotoxic cell proteinase gene expression and cytolytic activity by antiCD3-activated cytotoxic T lymphocytes is sensitive to cyclosporin A but is not dependent on interleukin-2 synthesis. J. Leukocyte Biol. 54:458.
23. Kaiser, M., and D. W. Hoskin. 1992. Expression and utilization of chymotrypsin-like but not trypsin-like serine protease enzymes by nonspecific T killer cells activated by anti-CD3 monoclonal antibody. Cell. Immunol. 141:84.
24. Singer-Sam, J., M. O. Robinson, A. R. Bellve, M. I. Simon, and A. D. Riggs. 1990. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res. 18:1255.
25. Stinchcombe, J. C., D. C. Barral, E. H. Mules, S. Booth, A. N. Hume, L. M. Machesky, M. C. Seabra, and G. M. Griffiths. 2001. Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J. Cell Biol. 152:825.
26. Smith, K. G., J. M. Austyn, G. Hariri, P. C. Beverley, and P. J. Morris. 1986. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors. Eur. J. Immunol. 16:478.
27. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
28. Ravetch, J. V., A. D. Luster, R. Weinshank, J. Kochan, A. Pavlovec, D. A. Portnoy, J. Hulmes, Y. C. Pan, and J. C. Unkeless. 1986. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science 234:718.
29. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76:519.
30. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
31. Sigal, L. J., H. Reiser, and K. L. Rock. 1998. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J. Immunol. 161:2740.
32. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156:465.
33. Makrigiannis, A. P., B. L. Musgrave, and D. W. Hoskin. 1999. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody. J Leukocyte Biol. 66:792.
34. Lancki, D. W., D. Qian, P. Fields, T. Gajewski, and F. W. Fitch. 1995. Differential requirement for protein tyrosine kinase Fyn in the functional activation of antigen-specific T lymphocyte clones through the TCR or Thy-1. J. Immunol. 154:4363.
35. Kojima, H., M. Toda, and M. V. Sitkovsky. 2000. Comparison of Fas-versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells. Int. Immunol. 12:365.
36. Williams, B. A., A. P. Makrigiannis, J. Blay, and D. W. Hoskin. 1997. Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibodymediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells. Int. J. Cancer 73:416.
37. Leyton, L., A. F. Quest, and C. Bron. 1999. Thy-1/CD3 coengagement promotes TCR signaling and enhances particularly tyrosine phosphorylation of the raft molecule LAT. Mol. Immunol. 36:755.
38. Amigorena, S. 2002. Fcγ receptors and cross-presentation in dendritic cells. J. Exp. Med. 195:F1.
39. - fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses. Immunology 101:242.
40. Fanger, N. A., D. Voigtlaender, C. Liu, S. Swink, K. Wardwell, J. Fisher, R. F. Graziano, L. C. Pfefferkom, and P. M. Guyre. 1997. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor FcγRI (CD64) expressed on human blood dendritic cells. J. Immunol. 158:3090.
41. Romani, N., K. Inaba, E. Pure, M. Crowley, M. Witmer-Pack, and R. M. Steinman. 1989. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes. J. Exp. Med. 169:1153.
42. Reiser, H., G. J. Freeman, Z. Razi-Wolf, C. D. Gimmi, B. Benacerraf, and L. M. Nadler. 1992. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc. Natl. Acad. Sci. USA 89:271.
43. Inaba, K., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849.
44. Ozery, T., G. Berke, M. Moscovich, K. Ozato, and Y. Kaufmann. 1989. T cell activation: independent induction of killing activity and interleukin 2 secretion in cytolytic hybridomas. Eur. J. Immunol. 19:1965.
45. Berke, G. 1995. The CTL's kiss of death. Cell 81:9.
46. Liu, C. C., S. Rafii, A. Granelli-Piperno, J. A. Trapani, and J. D. Young. 1989. Perforin and serine esterase gene expression in stimulated human T cells: kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 170:2105.
47. Makrigiannis, A. P., and D. W. Hoskin. 1997. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity. J. Immunol. 159:4700.
48. Schaffar, L., A. Dallanegra, J. P. Breittmayer, S. Carrel, and M. Fehlmann. 1988. Monoclonal antibody internalization and degradation during modulation of the CD3/T-cell receptor complex. Cell. Immunol. 116:52.
49. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
50. Gunter, K. C., R. N. Germain, R. A. Kroczek, T. Saito, W. M. Yokoyama, C. Chan, A. Weiss, and E. M. Shevach. 1987. Thy-1-mediated T-cell activation requires co-expression of CD3/Ti complex. Nature 326:505.
51. Schmitt-Verhulst, A. M., A. Guimezanes, C. Boyer, M. Poenie, R. Tsien, M. Buferne, C. Hua, and L. Leserman. 1987. Pleiotropic loss of activation pathways in a T cell receptor α-chain deletion variant of a cytolytic T-cell clone. Nature 325:628.
52. Haeryfar, S. M., and D. W. Hoskin. 2001. Selective pharmacological inhibitors reveal differences between Thy-1- and T cell receptor-mediated signal transduction in mouse T lymphocytes. Int. Immunopharmacol. 1:689.